Elinor is the Compliance Director at Knights.

Elinor advises and supports business clients following a whistleblowing allegation or when facing criminal or regulatory investigations by the Serious Fraud Office, Financial Conduct Authority, Competition & Markets’ Authority, HM Revenue & Customs, Crown Prosecution Service, the police and local government authorities.  In the event that an investigation proceeds to a prosecution, Elinor has successfully defended companies, directors and senior managers in a diverse range of cases including allegations of fraud, bribery and corruption, money laundering; and financial crimes including LIBOR fixing, sanctions violations, insider dealing, breach of listing rules, mis-selling financial products and competition issues.

Elinor also advises companies of all sizes on how to improve their compliance programmes and reduce the risk of corporate crime.  This includes regulatory and risk reviews; consultancy in regard to compliance programmes; implementation of policies and procedures; training to directors and employees on their personal obligations.

Elinor acts for companies and individual directors in a wide range of businesses, particularly in regulated sectors such as financial services and energy.  She often works on-site with corporate clients alongside senior management as part of their in-house legal or compliance team.

Recent examples of how Elinor has supported clients include:

  • successfully defending two directors of a pharmaceutical company in the Serious Fraud Office's prosecution for conspiracy to defraud the NHS by way of price-fixing and market-sharing;
  • implementing group-wide risk and compliance programmes for a major energy PLC to cover third party due diligence, investigations and whistleblowing programmes; as well as managing a team of 15 staff dealing with financial crime, fraud, bribery and corruption, export controls, modern slavery, sanctions and money laundering issues;
  • supporting a global investment bank through investigation and enforcement by the Financial Conduct Authority, in their first case under the Competition Act, which alleged breaches of systems and controls and employee misconduct;
  • recommending an action plan to remedy weaknesses in business compliance following a regulatory compliance review for the directors of a leading chain of garden centres; and
  • advising a global pharmaceutical company under investigation by the US Department of Justice and the UK Serious Fraud Office for allegations of bribery in several overseas jurisdictions.